Hill-Rom Holdings ROE 2006-2019 | HRC

Current and historical return on equity (ROE) values for Hill-Rom Holdings (HRC) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Hill-Rom Holdings ROE for the three months ending March 31, 2019 was 21.30%.
Hill-Rom Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2019-03-31 $0.23B $1.60B 14.47%
2018-12-31 $0.21B $1.55B 13.32%
2018-09-30 $0.25B $1.62B 16.53%
2018-06-30 $0.23B $1.51B 15.80%
2018-03-31 $0.19B $1.51B 13.64%
2017-12-31 $0.20B $1.46B 14.66%
2017-09-30 $0.13B $1.37B 10.42%
2017-06-30 $0.12B $1.29B 9.33%
2017-03-31 $0.16B $1.25B 12.70%
2016-12-31 $0.14B $1.20B 11.90%
2016-09-30 $0.12B $1.24B 10.42%
2016-06-30 $0.06B $1.20B 5.30%
2016-03-31 $0.04B $1.18B 3.39%
2015-12-31 $0.04B $1.15B 4.22%
2015-09-30 $0.05B $1.16B 5.55%
2015-06-30 $0.08B $0.77B 10.79%
2015-03-31 $0.09B $0.72B 11.48%
2014-12-31 $0.06B $0.74B 7.54%
2014-09-30 $0.06B $0.81B 7.44%
2014-06-30 $0.07B $0.83B 8.52%
2014-03-31 $0.07B $0.80B 8.23%
2013-12-31 $0.09B $0.84B 11.23%
2013-09-30 $0.10B $0.86B 12.63%
2013-06-30 $0.11B $0.81B 13.30%
2013-03-31 $0.11B $0.81B 13.27%
2012-12-31 $0.11B $0.82B 13.69%
2012-09-30 $0.12B $0.81B 15.04%
2012-06-30 $0.15B $0.81B 18.58%
2012-03-31 $0.12B $0.80B 16.19%
2011-12-31 $0.13B $0.77B 17.45%
2011-09-30 $0.13B $0.74B 17.96%
2011-06-30 $0.12B $0.75B 16.40%
2011-03-31 $0.15B $0.76B 20.87%
2010-12-31 $0.14B $0.73B 20.41%
2010-09-30 $0.13B $0.71B 18.95%
2010-06-30 $0.10B $0.68B 15.78%
2010-03-31 $0.09B $0.65B 14.48%
2009-12-31 $-0.40B $0.63B -66.20%
2009-09-30 $-0.41B $0.61B -56.92%
2009-06-30 $-0.41B $0.60B -49.05%
2009-03-31 $-0.41B $0.58B -42.91%
2008-12-31 $0.08B $1.06B 7.86%
2008-09-30 $0.12B $1.08B 10.17%
2008-06-30 $0.14B $1.08B 11.79%
2008-03-31 $0.16B $1.05B 12.67%
2007-12-31 $0.18B $1.31B 14.55%
2007-09-30 $0.19B $1.28B 15.53%
2007-06-30 $0.21B $1.26B 17.59%
2007-03-31 $0.23B $1.22B 19.60%
2006-12-31 $0.23B $1.17B 20.40%
2006-09-30 $0.22B $1.13B 20.84%
2006-06-30 $-0.08B $1.07B -7.45%
2006-03-31 $-0.09B $1.04B -8.63%
2005-12-31 $-0.09B $1.00B -8.52%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $7.099B $2.470B
HILL-ROM HOLDINGS, Inc. traces its roots back to 1929 when William A. Hillenbrand formed the company as a division of Hillenbrand Industries. At that time, the company was focused on developing innovative beds and furnishings for hospital patient rooms. Now, after nearly eighty years, Hill-Rom leads the way as an innovator in the medical technology field developing solutions that enhance outcomes for patients and their caregivers.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $146.709B 28.48
Medtronic (MDT) Ireland $133.941B 19.13
Stryker (SYK) United States $76.636B 27.35
Boston Scientific (BSX) United States $58.213B 27.91
Baxter (BAX) United States $41.870B 26.39
EssilorLuxottica Societe Anonyme (ESLOY) France $28.961B 0.00
Coloplast (CLPBY) Denmark $25.488B 40.69
Lonza Group Ag (LZAGY) Switzerland $25.277B 0.00
Zimmer Biomet Holdings (ZBH) United States $25.004B 16.06
Terumo (TRUMY) Japan $22.862B 26.29
Smith & Nephew SNATS (SNN) United Kingdom $19.073B 0.00
ResMed (RMD) United States $17.690B 33.80
Canopy Growth (CGC) Canada $12.296B 0.00
Sunny Optical Technology (SNPTF) China $12.175B 0.00
Bio-Rad Laboratories (BIO) United States $9.220B 48.88
William Demant Holdings (WILYY) Denmark $7.651B 0.00
Aurora Cannabis (ACB) Canada $7.261B 71.60
Insulet (PODD) United States $7.142B 520.35
Perrigo (PRGO) Ireland $6.850B 11.58
GN STORE NORD (GNNDY) Denmark $6.409B 32.73
Haemonetics (HAE) United States $6.283B 51.28
ICU Medical (ICUI) United States $5.126B 30.59
GW Pharmaceuticals (GWPH) United Kingdom $5.014B 0.00
Neogen (NEOG) United States $3.340B 54.31
Hutchison China MediTech (HCM) China $2.954B 0.00
NuVasive (NUVA) United States $2.945B 24.05
Agios Pharmaceuticals (AGIO) United States $2.762B 0.00
National Vision Holdings (EYE) United States $2.459B 52.40
Quidel (QDEL) United States $2.264B 23.50
Aphria (APHA) $1.581B 0.00
Cardiovascular Systems (CSII) United States $1.532B 879.80
Phibro Animal Health (PAHC) United States $1.229B 18.42
AtriCure (ATRC) United States $1.186B 0.00
VAREX IMAGING (VREX) United States $1.172B 24.87
Lantheus Holdings (LNTH) United States $1.081B 28.70
NanoString Technologies (NSTG) United States $1.069B 0.00
PetIQ (PETQ) United States $1.001B 24.32
Quanterix (QTRX) United States $0.773B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.758B 21.26
Cerus (CERS) United States $0.757B 0.00
Omeros (OMER) United States $0.747B 0.00
MacroGenics (MGNX) United States $0.742B 0.00
TG Therapeutics (TGTX) United States $0.693B 0.00
LeMaitre Vascular (LMAT) United States $0.583B 28.24
Surmodics (SRDX) United States $0.531B 77.12
OraSure Technologies (OSUR) United States $0.527B 24.26
Meridian Bioscience (VIVO) United States $0.487B 14.90
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.393B 0.00
Vapotherm (VAPO) United States $0.337B 0.00
Utah Medical Products (UTMD) United States $0.325B 22.53
BioLife Solutions (BLFS) United States $0.311B 97.35
Zynex (ZYXI) United States $0.239B 24.53
Cytosorbents (CTSO) United States $0.232B 0.00
Bovie Medical (APYX) United States $0.228B 0.00
Owens & Minor (OMI) United States $0.192B 4.07
Chimerix (CMRX) United States $0.188B 0.00
United Health Products (UEEC) United States $0.174B 0.00
Rockwell Medical (RMTI) United States $0.173B 0.00
Female Health (VERU) United States $0.147B 0.00
Fonar (FONR) United States $0.137B 7.22
Chembio Diagnostics (CEMI) United States $0.101B 0.00
United-Guardian (UG) United States $0.094B 20.60
InfuSystems Holdings (INFU) United States $0.092B 0.00
Surface Oncology (SURF) United States $0.074B 0.00
Trinity Biotech (TRIB) Ireland $0.062B 21.58
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
MRI INTERVENTNS (MRIC) United States $0.052B 0.00